DE3830721A1
(de)
|
1988-09-09 |
1990-03-22 |
Michael Dr Menton |
In labors, insbesondere in medizinischen labors, zu verwendender objekttraeger
|
AU9233698A
(en)
|
1997-11-22 |
1999-06-17 |
Robert A. Levine |
Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
|
US6197523B1
(en)
*
|
1997-11-24 |
2001-03-06 |
Robert A. Levine |
Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
|
US6670197B2
(en)
|
1997-11-24 |
2003-12-30 |
David L. Rimm |
Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments
|
US20010018058A1
(en)
|
1997-12-24 |
2001-08-30 |
Reed Steven G. |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
US8192994B2
(en)
|
1998-02-10 |
2012-06-05 |
Angros Lee H |
Method of applying a biological specimen to an analytic plate
|
BR9907852A
(pt)
|
1998-02-12 |
2000-10-24 |
Immunivest Corp |
Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes
|
JP2002514762A
(ja)
|
1998-05-09 |
2002-05-21 |
アイコニシス,インコーポレーテッド |
コンピュータによって制御された、胎児細胞を含む希少細胞に基づく診断のための方法および装置
|
US6960449B2
(en)
|
1999-02-10 |
2005-11-01 |
Cell Works Diagnostics, Inc. |
Class characterization of circulating cancer cells isolated from body fluids and methods of use
|
US7546210B2
(en)
|
2000-06-08 |
2009-06-09 |
The Regents Of The University Of California |
Visual-servoing optical microscopy
|
US7033832B2
(en)
|
2000-10-13 |
2006-04-25 |
University Of Medicine And Dentistry Of New Jersey |
Endothelial cell—cell cohesion
|
AU2001297830A1
(en)
|
2000-10-25 |
2002-12-09 |
Exiqon A/S |
Closed substrate platforms suitable for analysis of biomolecules
|
EP1666881B1
(en)
|
2001-05-04 |
2010-02-17 |
Biosite Incorporated |
Diagnostic markers of acute coronary syndromes and methods of use thereof
|
US20080009019A1
(en)
|
2001-06-13 |
2008-01-10 |
Smithkline Beecham Corporation |
High throughput method for screening candidate compounds for biological activity
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
BR0212124A
(pt)
|
2001-08-23 |
2004-07-20 |
Immunivest Corp |
Composições, métodos e aparelhos para conservar espécimes biológicos e amostras de sangue suspeitas de conter células tumorais circulantes, e, composição celular estabilizada
|
US7943093B2
(en)
|
2001-12-12 |
2011-05-17 |
Erie Scientific Company |
Cover slip
|
EP1474772A4
(en)
|
2002-02-14 |
2005-11-09 |
Immunivest Corp |
METHOD AND ALGORITHMS FOR CELL DETERMINATION IN A COST-EFFECTIVE CYTOMETER
|
US7113624B2
(en)
|
2002-10-15 |
2006-09-26 |
Palo Alto Research Center Incorporated |
Imaging apparatus and method employing a large linear aperture
|
US7305112B2
(en)
|
2002-10-15 |
2007-12-04 |
The Scripps Research Institute |
Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
|
US7282180B2
(en)
|
2003-07-02 |
2007-10-16 |
Immunivest Corporation |
Devices and methods to image objects
|
US7372985B2
(en)
|
2003-08-15 |
2008-05-13 |
Massachusetts Institute Of Technology |
Systems and methods for volumetric tissue scanning microscopy
|
WO2005100999A2
(en)
|
2004-04-08 |
2005-10-27 |
Cornell Research Foundation, Inc. |
Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
|
WO2006041453A1
(en)
|
2004-09-30 |
2006-04-20 |
Immunivest Corporation |
Circulating tumor cells (ctc’s): apoptotic assessment in prostate cancer patients
|
JP5058815B2
(ja)
|
2004-11-24 |
2012-10-24 |
バッテル メモリアル インスティチュート |
細胞撮像用の光学システム
|
US7280261B2
(en)
|
2004-12-20 |
2007-10-09 |
Palo Alto Research Center Incorporated |
Method of scanning and light collection for a rare cell detector
|
US20090081688A1
(en)
|
2005-06-20 |
2009-03-26 |
Advanced Cell Diagnostics |
Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
|
US20070009389A1
(en)
|
2005-07-08 |
2007-01-11 |
Antti Seppo |
Slide deposition chamber
|
US9134237B2
(en)
*
|
2005-09-20 |
2015-09-15 |
Janssen Diagnotics, LLC |
High sensitivity multiparameter method for rare event analysis in a biological sample
|
ES2420834T3
(es)
|
2006-01-30 |
2013-08-27 |
The Scripps Research Institute |
Métodos de detección de células tumorales circulantes y métodos de diagnóstico del cáncer en un sujeto mamífero
|
US8337755B2
(en)
|
2006-03-13 |
2012-12-25 |
Veridex, Llc |
Operator independent programmable sample preparation and analysis system
|
US20080076727A1
(en)
|
2006-03-29 |
2008-03-27 |
John Wayne Cancer Institute |
Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
|
US20090105963A1
(en)
|
2006-05-13 |
2009-04-23 |
Jesper Laursen |
Methods for Flow Cytometry Analyses of Un-Lysed Cells from Biological Fluids
|
PL2027470T3
(pl)
|
2006-06-02 |
2013-03-29 |
Pfizer Prod Inc |
Oznaczenie krążących komórek nowotworowych
|
WO2008111990A1
(en)
|
2006-06-14 |
2008-09-18 |
Cellpoint Diagnostics, Inc. |
Rare cell analysis using sample splitting and dna tags
|
US20080113358A1
(en)
|
2006-07-28 |
2008-05-15 |
Ravi Kapur |
Selection of cells using biomarkers
|
CN104964908A
(zh)
|
2006-09-05 |
2015-10-07 |
维里德克斯有限责任公司 |
细胞图像的归类方法
|
US8244021B2
(en)
|
2006-12-20 |
2012-08-14 |
Ventana Medical Systems, Inc. |
Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
|
CN101226118B
(zh)
|
2007-01-19 |
2010-06-16 |
中国医学科学院肿瘤研究所 |
一种兼容免疫荧光分析的细胞化学染色方法及其用途
|
US20100184629A1
(en)
|
2007-06-05 |
2010-07-22 |
Nanopoint, Inc. |
Cell tray systems and methods
|
EP2201134B1
(en)
|
2007-09-19 |
2018-11-21 |
The Research Foundation of State University of New York |
Gene expression signatures in enriched tumor cell samples
|
WO2009051734A1
(en)
|
2007-10-17 |
2009-04-23 |
The General Hospital Corporation |
Microchip-based devices for capturing circulating tumor cells and methods of their use
|
WO2009064933A2
(en)
|
2007-11-13 |
2009-05-22 |
Ikonisys, Inc. |
Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
|
US20090258365A1
(en)
*
|
2008-03-25 |
2009-10-15 |
Terstappen Leon W M M |
METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
|
WO2010005991A2
(en)
|
2008-07-07 |
2010-01-14 |
The Board Of Regents Of The University Of Texas System |
Circulating tumor and tumor stem cell detection using genomic specific probes
|
US9779213B2
(en)
|
2008-07-25 |
2017-10-03 |
Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud |
System for evaluating a pathological stage of prostate cancer
|
US8324280B2
(en)
|
2008-08-07 |
2012-12-04 |
The University Of British Columbia |
Treatment of prostate cancer with DDC inhibitor
|
CA2736178A1
(en)
|
2008-09-05 |
2010-03-11 |
Peter Kuhn |
Methods for the detection of circulating tumor cells
|
EP2491395B1
(en)
|
2009-10-21 |
2015-09-16 |
The Scripps Research Institute |
Method of using non-rare cells to detect rare cells
|
CA2788245A1
(en)
|
2010-01-27 |
2011-08-04 |
Duke University |
Biomarkers for circulating tumor cells
|
CA2791244A1
(en)
|
2010-03-08 |
2011-09-15 |
Regents Of The University Of Minnesota |
Androgen receptor isoforms and methods
|
TWI539158B
(zh)
|
2010-06-08 |
2016-06-21 |
維里德克斯有限責任公司 |
使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
|
WO2012048113A2
(en)
|
2010-10-07 |
2012-04-12 |
The General Hospital Corporation |
Biomarkers of cancer
|
WO2012092426A1
(en)
|
2010-12-30 |
2012-07-05 |
Foundation Medicine, Inc. |
Optimization of multigene analysis of tumor samples
|
WO2012103025A2
(en)
|
2011-01-24 |
2012-08-02 |
Epic Sciences, Inc. |
Methods for obtaining single cells and applications of single cell omics
|
CN103782170A
(zh)
|
2011-07-07 |
2014-05-07 |
斯克里普斯健康机构 |
分析心血管病症的方法及其用途
|
US20130078667A1
(en)
|
2011-09-22 |
2013-03-28 |
Oscar B. Goodman |
Methods for detecting and collecting circulating tumor cells
|
WO2013049926A1
(en)
|
2011-10-06 |
2013-04-11 |
UNIVERSITé LAVAL |
PROGNOSTIC MARKERS OF INHERITED VARIATIONS IN THE 17β-HYDROXYSTEROID DEHYDROGENASE (HSD17B) GENES FOR PROSTATE CANCER
|
AU2012347526A1
(en)
|
2011-12-09 |
2014-07-10 |
Gerd MARIENFELD |
Apparatus, system and method for identifying circulating tumor cells
|
DK2798355T3
(en)
|
2011-12-30 |
2018-12-03 |
Ventana Med Syst Inc |
Automated analysis of circulating tumor cells
|
BR112014018192A8
(pt)
*
|
2012-01-24 |
2021-03-02 |
Epic Sciences Inc |
método e kit para detecção de células tumorais circulantes 5t4-positivas, bem como métodos de diagnóstico de câncer 5t4-positivo e de seleção para atividade e eficácia de conjugado fármaco-anticorpo para tratamento de câncer
|
ES2917399T3
(es)
|
2012-06-01 |
2022-07-08 |
Creatv Microtech Inc |
Captura, identificación y uso de un nuevo marcador de tumores sólidos en fluidos corporales
|
US9766244B2
(en)
|
2012-07-02 |
2017-09-19 |
The General Hospital Corporation |
Diagnosis and monitoring treatment of prostate cancer
|
US20140024024A1
(en)
*
|
2012-07-17 |
2014-01-23 |
General Electric Company |
Methods of detecting dna, rna and protein in biological samples
|
WO2014047285A1
(en)
|
2012-09-19 |
2014-03-27 |
Paraskevi Giannakakou |
Identifying taxane sensitivity in prostate cancer patients
|
US10206911B2
(en)
|
2012-10-26 |
2019-02-19 |
Memorial Sloan-Kettering Cancer Center |
Androgen receptor variants and methods for making and using
|
US10161939B2
(en)
|
2013-02-02 |
2018-12-25 |
Duke University |
Method of isolating circulating tumor cells
|
CA2905798C
(en)
|
2013-03-15 |
2023-01-24 |
Genentech, Inc. |
Biomarkers and methods of treating pd-1 and pd-l1 related conditions
|
NZ712663A
(en)
|
2013-04-05 |
2021-07-30 |
Myriad Genetics Inc |
Methods and materials for assessing homologous recombination deficiency
|
EP3052940B1
(en)
|
2013-09-30 |
2021-05-26 |
The Scripps Research Institute |
Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients
|
WO2015073896A2
(en)
|
2013-11-15 |
2015-05-21 |
Psma Development Company, Llc |
Biomarkers for psma targeted therapy for prostate cancer
|
US20170192003A1
(en)
|
2013-12-03 |
2017-07-06 |
The Scripps Research Institute |
Compositions and methods for fluid biopsy of melanoma
|
US20150185204A1
(en)
|
2013-12-30 |
2015-07-02 |
The Scripps Research Institute |
Circulating tumor cell diagnostics for lung cancer
|
EP3100046B1
(en)
|
2014-01-27 |
2022-04-20 |
Epic Sciences, Inc. |
Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
|
EA201691496A1
(ru)
|
2014-01-27 |
2016-12-30 |
Эпик Сайенсиз, Инк. |
Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
|
EP3099821B1
(en)
|
2014-01-27 |
2021-08-11 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
|
EP3100052B1
(en)
|
2014-01-30 |
2021-03-10 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies
|
WO2015116780A1
(en)
|
2014-01-31 |
2015-08-06 |
Epic Sciences, Inc. |
Methods for the detection and quantification of circulating tumor cell mimics
|
US10545151B2
(en)
|
2014-02-21 |
2020-01-28 |
Epic Sciences, Inc. |
Methods for analyzing rare circulating cells
|
WO2016049291A1
(en)
|
2014-09-25 |
2016-03-31 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies
|
EP3207377A4
(en)
|
2014-10-15 |
2018-05-02 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for therapy targeting pd-l1
|
WO2016196284A1
(en)
|
2015-05-29 |
2016-12-08 |
Epic Sciences, Inc. |
Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc)
|
CA3004150A1
(en)
|
2015-11-03 |
2017-05-11 |
Epic Sciences, Inc. |
Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity
|
EA201891571A1
(ru)
|
2016-01-06 |
2019-01-31 |
Эпик Сайенсиз, Инк. |
Геномное профилирование отдельных циркулирующих опухолевых клеток (ctc) при метастазирующем заболевании для характеризации гетерогенности заболевания
|